June 12, 2020 / 12:09 PM / a month ago

BRIEF-I-Mab And ABL Bio To Present Preclinical Data For Joint Bispecific Antibody Program

June 12 (Reuters) - I-Mab:

* I-MAB AND ABL BIO TO PRESENT PRECLINICAL DATA FOR JOINT BISPECIFIC ANTIBODY PROGRAM AT THE 2020 AMERICAN ASSOCIATION FOR CANCER RESEARCH VIRTUAL MEETING II Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below